These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32359088)

  • 1. RAAS blockers in hypertension posing a higher risk toward the COVID-19.
    Singh Y; Gupta G; Satija S; Negi P; Chellappan DK; Dua K
    Dermatol Ther; 2020 Jul; 33(4):e13501. PubMed ID: 32359088
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2.
    Lévy BI; Fauvel JP;
    Arch Cardiovasc Dis; 2020; 113(8-9):572-578. PubMed ID: 32863157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
    Danser AHJ; Epstein M; Batlle D
    Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
    Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
    J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
    Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertension and RAAS inhibition in times of COVID-19 - current recommendations of the European Society of Hypertension.].
    Limbourg FP
    MMW Fortschr Med; 2020 May; 162(9):67-69. PubMed ID: 32405833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
    Cadegiani FA; Goren A; Wambier CG
    Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: ACE2centric Infective Disease?
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Hypertension; 2020 Aug; 76(2):294-299. PubMed ID: 32476472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.
    Vistisen ST; Bodilsen J; Scheeren TWL; Simonsen U
    Eur J Anaesthesiol; 2020 Sep; 37(9):739-742. PubMed ID: 32769503
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19.
    Kow CS; Zaidi STR; Hasan SS
    Am J Cardiovasc Drugs; 2020 Jun; 20(3):217-221. PubMed ID: 32281055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.
    Sparks MA; South A; Welling P; Luther JM; Cohen J; Byrd JB; Burrell LM; Batlle D; Tomlinson L; Bhalla V; Rheault MN; Soler MJ; Swaminathan S; Hiremath S
    Clin J Am Soc Nephrol; 2020 May; 15(5):714-716. PubMed ID: 32220930
    [No Abstract]   [Full Text] [Related]  

  • 16. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
    Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
    N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
    [No Abstract]   [Full Text] [Related]  

  • 17. Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.
    Rodrigues CIS
    J Bras Nefrol; 2020 Aug; 42(2 suppl 1):47-48. PubMed ID: 32877500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
    Huang Y; Xie C; Chen X; Hong Q; Huang H
    Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
    [No Abstract]   [Full Text] [Related]  

  • 19. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?
    Battistoni A; Volpe M
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):248-251. PubMed ID: 32286607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
    Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
    Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.